A Prospective Biopsychosocial Repeated Measures Study of Stress and Dropout from Substance Addiction Treatment

References

• Malivert M, Fatséas M, Denis C, Langlois E, Auriacombe M. Effectiveness of therapeutic communities: a systematic review. Eur Addict Res. 2012;18(1):1–11. doi:10.1159/000331007
   PubMed Web of Science ®Google Scholar
• Andersson HW, Wenaas M, Nordfjærn T. Relapse after inpatient substance use treatment: a prospective cohort study among users of illicit substances. Addict Behav. 2019;90:222–228. doi:10.1016/j.addbeh.2018.11.008
   PubMed Web of Science ®Google Scholar
• Hubbard RL, Craddock SG, Anderson J. Overview of 5-year followup outcomes in the drug abuse treatment outcome studies (DATOS). J Subst Abuse Treat. 2003;25(3):125–134. doi:10.1016/S0740-5472(03)00130-2
   PubMed Web of Science ®Google Scholar
• Magor-Blatch L, Bhullar N, Thomson B, Thorsteinsson E. A systematic review of studies examining effectiveness of therapeutic communities. Ther Communities. 2014;35(4):168–184. doi:10.1108/TC-07-2013-0024/FULL/XML
   Google Scholar
• Magill M, Ray LA. Cognitive-behavioral treatment with adult alcohol ad illicit drug users: a meta-analysis of randomized controlled trials*. J Stud Alcohol Drugs. 2009;70(4):516–527. doi:10.15288/jsad.2009.70.516
   PubMed Web of Science ®Google Scholar
• McHugh RK, Hearon BA, Otto MW. Cognitive-behavioral therapy for substance use disorders. Psychiatr Clin North Am. 2010;33(3):511. doi:10.1016/j.psc.2010.04.012
   PubMed Web of Science ®Google Scholar
• Haviv N, Hasisi B. Prison addiction program and the role of integrative treatment and program completion on recidivism. Int J Offender Ther Comp Criminol. 2019;63:15–16. doi:10.1177/0306624X19871650
   Web of Science ®Google Scholar
• Shoham E, Efodi R, Haviv N, Gross Shader C. Dropout from treatment and desistance from crime among released prisoners in Jerusalem halfway house for prisoners with substance misuse disorder. Int J Offender Ther Comp Criminol. 2022;66(10–11):1109–1133. doi:10.1177/0306624X211010291
   PubMed Web of Science ®Google Scholar
• Ligabue KP, Schuch JB, Scherer JN, et al. Increased cortisol levels are associated with low treatment retention in crack cocaine users. Addict Behav. 2020;103:106260. doi:10.1016/J.ADDBEH.2019.106260
   PubMed Web of Science ®Google Scholar
• Stark MJ. Dropping out of substance abuse treatment: a clinically oriented review. Clin Psychol Rev. 1992;12(1):93–116. doi:10.1016/0272-7358(92)90092-M
   Web of Science ®Google Scholar
• López-Goñi JJ, Fernández-Montalvo J, Arteaga A. Addiction treatment dropout: exploring patients’ characteristics. Am J Addict. 2012;21(1):78–85. doi:10.1111/j.1521-0391.2011.00188.x
   PubMed Web of Science ®Google Scholar
• López-goñi JJ, Fernández- Montalvo J, Illescas C, Landa N, Lorea I. Determining socio-demographic predictors of treatment dropout: results in a therapeutic community. Int J Soc Welf. 2008;17(4):374–378. doi:10.1111/j.1468-2397.2008.00584.x
   Web of Science ®Google Scholar
• Li X, Sun H, Puri A, Marsh DC, Anis AH. Factors associated with pretreatment and treatment dropouts among clients admitted to medical withdrawal management. J Addict Dis. 2007;26(3):77–85. doi:10.1300/J069v26n03_08
   PubMed Web of Science ®Google Scholar
• Baekeland F, Lundwall L. Dropping out of treatment: a critical review. Psychol Bull. 1975;82(5):738–783. doi:10.1037/h0077132
   PubMed Web of Science ®Google Scholar
• Darke S, Campbell G, Popple G. Retention, early dropout and treatment completion among therapeutic community admissions. Drug Alcohol Rev. 2012;31(1):64–71. doi:10.1111/j.1465-3362.2011.00298.x
   PubMed Web of Science ®Google Scholar
• Andersson HW, Steinsbekk A, Walderhaug E, Otterholt E, Nordfjærn T. Predictors of dropout from inpatient substance use treatment: a prospective cohort study. Subst Abuse. 2018;12:1178221818760551. doi:10.1177/1178221818760551
   Web of Science ®Google Scholar
• Brorson HH, Ajo Arnevik E, Rand-Hendriksen K, Duckert F. Drop-out from addiction treatment: a systematic review of risk factors. Clin Psychol Rev. 2013;33(8):1010–1024. doi:10.1016/j.cpr.2013.07.007
   PubMed Web of Science ®Google Scholar
• Andersson HW, Otterholt E, Gråwe RW. Patient satisfaction with treatments and outcomes in residential addiction institutions. Nord Stud Alcohol Drugs. 2017;34(5):375–384. doi:10.1177/1455072517718456
   Web of Science ®Google Scholar
• Brorson HH, Arnevik EA, Rand K. Predicting dropout from inpatient substance use disorder treatment: a prospective validation study of the OQ-analyst. Subst Abuse. 2019;13. doi:10.1177/1178221819866181
   PubMed Web of Science ®Google Scholar
• Lintzeris N, Monds LA, Rivas G, Leung S, Withall A, Draper B. The Australian treatment outcomes profile instrument as a clinical tool for older alcohol and other drug clients: a validation study. Drug Alcohol Rev. 2016;35:6. doi:10.1111/dar.12393
   PubMed Web of Science ®Google Scholar
• Campbell A, Hemsley S. Outcome rating scale and session rating scale in psychological practice: clinical utility of ultra-brief measures. Clin Psychol. 2009;13(1):1–9. doi:10.1080/13284200802676391
   Web of Science ®Google Scholar
• Lambert MJ, Hansen NB, Finch AE. Patient-focused research: using patient outcome data to enhance treatment effects. J Consult Clin Psychol. 2001;69(2):2. doi:10.1037/0022-006X.69.2.159
   Web of Science ®Google Scholar
• Engel GL. The need for a new medical model: a challenge for biomedicine. Science. 1977;196(4286):129–196. doi:10.1126/science.847460
   PubMed Web of Science ®Google Scholar
• Stallvik M. Biopsykososial tilnærming til rusavhengighet. Rusfag. 2011;1:105–112.
   Google Scholar
• Marlatt GA, Baer JS, Donovan DM, Kivlahan DR. Addictive behaviors: etiology and treatment. Ann Rev Psychol. 1988;39:223–252. doi:10.1146/annurev.ps.39.020188.001255
   PubMed Web of Science ®Google Scholar
• Volpicelli J, Pettinati R, McLellan HM, et al. The biopsychosocial understanding of addiction. In: Combining Medication and Psychosocial Treatments for Addictions: The BRENDA Approach. New York, NY: Guilford Press; 2001:3–15.
   Google Scholar
• Daughters SB, Richards JM, Gorka SM, Sinha R. HPA axis response to psychological stress and treatment retention in residential substance abuse treatment: a prospective study. Drug Alcohol Depend. 2009;105(3):202–208. doi:10.1016/j.drugalcdep.2009.06.026
   PubMed Web of Science ®Google Scholar
• Daughters SB, Lejuez CW, Bornovalova MA, Kahler CW, Strong DR, Brown RA. Distress tolerance as a predictor of early treatment dropout in a residential substance abuse treatment facility. J Abnorm Psychol. 2005;114(4):729–734. doi:10.1037/0021-843X.114.4.729
   PubMed Web of Science ®Google Scholar
• Rozynko VV, Stein KB. Social and psychological factors associated with length of stay in a drug treatment facility. Int J Addict. 1974;9(6):873–878. doi:10.3109/10826087409022181
   PubMed Web of Science ®Google Scholar
• Dziurkowska E, Wesolowski M. Cortisol as a biomarker of mental disorder severity. J Clin Med. 2021;10(21):5204. doi:10.3390/jcm10215204
   PubMed Web of Science ®Google Scholar
• Hellhammer DH, Wüst S, Kudielka BM. Salivary cortisol as a biomarker in stress research. Psychoneuroendocrinology. 2009;34(2):163–171. doi:10.1016/J.PSYNEUEN.2008.10.026
   PubMed Web of Science ®Google Scholar
• Junghanns K, Tietz U, Dibbelt L, et al. Attenuated salivary cortisol secretion under cue exposure is associated with early relapse. Alcohol Alcohol. 2005;40(1):80–85. doi:10.1093/ALCALC/AGH107
   PubMed Web of Science ®Google Scholar
• Moss HB, Vanyukov MM, Martin CS. Salivary cortisol responses and the risk for substance abuse in prepubertal boys. Biol Psychiatry. 1995;38(8):547–555. doi:10.1016/0006-3223(94)00382-D
   PubMed Web of Science ®Google Scholar
• Szabo YZ, Breeding T, Hejl C, Guleria RS, Nelson SM, Zambrano-Vazquez L. Cortisol as a biomarker of alcohol use in combat veterans: a literature review and framework for future research. J Dual Diagn. 2020;16(3):322–335. doi:10.1080/15504263.2020.1771504
   PubMed Web of Science ®Google Scholar
• Lovallo WR, Cohoon AJ, Sorocco KH. Early-life adversity and blunted stress reactivity as predictors of alcohol and drug use in persons with COMT (rs4680) Val158Met genotypes. Alcohol Clin Exp Res. 2019;43(7):1519–1527. doi:10.1111/acer.14079
   PubMed Web of Science ®Google Scholar
• Adinoff B, Junghanns K, Kiefer F, Krishnan-Sarin S. Suppression of the HPA axis stress-response: implications for relapse. Alcohol Clin Exp Res. 2005;29(7):1351. doi:10.1097/01.ALC.0000176356.97620.84
   PubMed Web of Science ®Google Scholar
• Sinha R. New findings on biological factors predicting addiction relapse vulnerability. Curr Psychiatry Rep. 2011;13(5):398–405. doi:10.1007/s11920-011-0224-0
   PubMed Web of Science ®Google Scholar
• Jaremko KM, Sterling RC, van Bockstaele EJ. Psychological and physiological stress negatively impacts early engagement and retention of opioid-dependent individuals on methadone maintenance. J Subst Abuse Treat. 2015;48(1):117–127. doi:10.1016/j.jsat.2014.08.006
   PubMed Web of Science ®Google Scholar
• Sinha R. How does stress increase risk of drug abuse and relapse? Psychopharmacology. 2001;158(4):343–359. doi:10.1007/s002130100917
   PubMed Web of Science ®Google Scholar
• Ali B, Green KM, Daughters SB, Lejuez CW. Distress tolerance interacts with circumstances, motivation, and readiness to predict substance abuse treatment retention. Addict Behav. 2017;73:99–104. PMID: 28500908; PMCID: PMC5542844. doi:10.1016/j.addbeh.2017.04.016
   PubMed Web of Science ®Google Scholar
• Gragera-Martinez Á, León-Justel A, Arriero LH, Alor FB, Vazquez IR. Cortisol in saliva to predict relapse in patients addicted to cocaine use. Clin Chim Acta. 2019;493:S328–S329. doi:10.1016/j.cca.2019.03.712
   Web of Science ®Google Scholar
• Sinha R, Garcia M, Paliwal P, Kreek MJ, Rounsaville BJ. Stress-induced cocaine craving and hypothalamic-pituitary-adrenal responses are predictive of cocaine relapse outcomes. Arch Gen Psychiatry. 2006;63(3):324–331. doi:10.1001/archpsyc.63.3.324
   PubMed Web of Science ®Google Scholar
• Fox HC, Jackson ED, Sinha R. Elevated cortisol and learning and memory deficits in cocaine dependent individuals: relationship to relapse outcomes. Psychoneuroendocrinology. 2009;34(8):1198–1207. doi:10.1016/J.PSYNEUEN.2009.03.007
   PubMed Web of Science ®Google Scholar
• Contoreggi C, Herning RI, Koeppl B, et al. Treatment-seeking inpatient cocaine abusers show hypothalamic dysregulation of both basal prolactin and cortisol secretion. Neuroendocrinology. 2003;78(3):154–162. doi:10.1159/000072797
   PubMed Web of Science ®Google Scholar
• Wisniewski AB, Brown TT, John M, et al. Cortisol levels and depression in men and women using heroin and cocaine. Auernhammer Brockmeyer Brown Brown Cami Cooper Facchinetti Golub Golub Greene Heim Jiang Kuhn Laudat Leserman Linkowski Lortholary Martin Mayo Nock Plotsky Rubin Varghese Villette Wisniewski Wizemann Young Zhou A, ed. Psychoneuroendocrinology. 2006;31(2):250–255. doi:10.1016/j.psyneuen.2005.08.002
   PubMed Web of Science ®Google Scholar
• Rao U, Hammen CL, Poland RE. Mechanisms underlying the comorbidity between depressive and addictive disorders in adolescents: interactions between stress and HPA activity. Am J Psychiatry. 2009;166(3):361–369. doi:10.1176/appi.ajp.2008.08030412
   PubMed Web of Science ®Google Scholar
• Adinoff B, Iranmanesh A, Veldhuis J, Fisher L. Disturbances of the stress response: the role of the HPA axis during alcohol withdrawal and abstinence. Alcohol Health Res World. 1998;22(1):67.
   PubMedGoogle Scholar
• Adinoff B, Krebaum SR, Chandler PA, Ye W, Brown MB, Williams MJ. Dissection of hypothalamic-pituitary-adrenal axis pathology in 1-month-abstinent alcohol-dependent men, part 1: adrenocortical and pituitary glucocorticoid responsiveness. Alcohol Clin Exp Res. 2005;29(4):517–527. doi:10.1097/01.ALC.0000158940.05529.0A
   PubMedGoogle Scholar
• Cuttler C, Spradlin A, Nusbaum AT, Whitney P, Hinson JM, McLaughlin RJ. Blunted stress reactivity in chronic cannabis users. Psychopharmacology. 2017;234(15):2299–2309. doi:10.1007/S00213-017-4648-Z/FIGURES/5
   PubMed Web of Science ®Google Scholar
• Stephens MAC, Wand G. Stress and the HPA Axis Role of Glucocorticoids in Alcohol Dependence. Alcohol res. 2012;34(4):468–483.
   PubMed Web of Science ®Google Scholar
• Peles E, Malik E, Altman Y, et al. Stress indices in methadone maintenance treatment - cross sectional and follow up study. Psychiatry Res. 2020;291:113218. doi:10.1016/J.PSYCHRES.2020.113218
   PubMed Web of Science ®Google Scholar
• Bøhle K, Otterholt E, Bjørkly S. Is there an association between salivary cortisol and dropping out of inpatient substance addiction treatments? A prospective repeated measures study. Subst Abuse. 2022;16. doi:10.1177/11782218221106797
   PubMed Web of Science ®Google Scholar
• Santucci K. Psychiatric disease and drug abuse. Curr Opin Pediatr. 2012;24(2):233–237. doi:10.1097/MOP.0B013E3283504FBF
   PubMed Web of Science ®Google Scholar
• Burdzovic Andreas J, Lauritzen G, Nordfjærn T. Co-occurrence between mental distress and poly-drug use: a ten year prospective study of patients from substance abuse treatment. Addict Behav. 2015;48:71–78. doi:10.1016/j.addbeh.2015.05.001
   PubMed Web of Science ®Google Scholar
• Løberg EM, Helle S, Nygard M, et al. The cannabis pathway to non-affective psychosis may reflect less neurobiological vulnerability. Front Psychiatry. 2014;5(OCT):159. doi:10.3389/fpsyt.2014.00159
   PubMedGoogle Scholar
• Bramness JG, Gundersen ØH, Guterstam J, et al. Amphetamine-induced psychosis - a separate diagnostic entity or primary psychosis triggered in the vulnerable? BMC Psychiatry. 2012;12(1):1–7. doi:10.1186/1471-244X-12-221/FIGURES/1
   PubMedGoogle Scholar
• Landheim AS, Bakken K, Vaglum P. Impact of comorbid psychiatric disorders on the outcome of substance abusers: a six year prospective follow-up in two Norwegian counties. BMC Psychiatry. 2006;6(1). doi:10.1186/1471-244X-6-44
   PubMedGoogle Scholar
• Simpson DD, Joe G, Rowan-Szal GA, Greener JM. Drug abuse treatment process components that improve retention outcome assessment of correctional treatment view project TERESA view project. J Subst Abuse Treat. 1997;14(6):565–572. doi:10.1016/S0740-5472(97)00181-5
   PubMed Web of Science ®Google Scholar
• Hassel A, Nordfjaern T, Hagen R. Journal of substance use psychological and interpersonal distress among patients with substance use disorders: are these factors associated with continued drug use and do they change during treatment?) Psychological and interpersonal distress among patients with substance use disorders: are these factors associated with continued drug use and do they change during treatment? J Subst Use. 2012;18(5):363–376. doi:10.3109/14659891.2012.685122
   Web of Science ®Google Scholar
• Ormbostad HAK, Otterholt E, Stallvik M. Investigating patients’ perceptions of residential substance use treatment. Is drop out a deliberate or impulsive act? J Soc Work Pract Addict. 2021;21(3):255–272. doi:10.1080/1533256X.2021.1933850
   Web of Science ®Google Scholar
• Adinoff B, Martin PR, Bone GHA, et al. Hypothalamic-pituitary-adrenal axis functioning and cerebrospinal fluid corticotropin releasing hormone and corticotropin levels in alcoholics after recent and long-term abstinence. Arch Gen Psychiatry. 1990;47(4):325–330. doi:10.1001/ARCHPSYC.1990.01810160025004
   PubMed Web of Science ®Google Scholar
• Carr WA, Ball SA. Predictors and treatment outcomes of perceived ward atmosphere among therapeutic community residents. J Subst Abuse Treat. 2014;46(5):567–573. doi:10.1016/j.jsat.2014.01.003
   PubMed Web of Science ®Google Scholar
• Verinis JS. Ward atmosphere as a factor in irregular discharge from an alcohol rehabilitation unit. Int J Addict. 1983;18(6):895–899. doi:10.3109/10826088309033057
   PubMed Web of Science ®Google Scholar
• Fischer J. The relationship between alcoholic patients’ milieu perception and measures of their drinking during a brief follow-up period. Int J Addict. 2009;14(8):1151–1156. doi:10.3109/10826087909048704
   Google Scholar
• Beckwith M, Best D, Dingle G, Perryman C, Lubman D. Alcoholism treatment quarterly predictors of flexibility in social identity among people entering a therapeutic community for substance abuse. Alcohol Treat Q. 2015;33(1):93–104. doi:10.1080/07347324.2015.982465
   Web of Science ®Google Scholar
• Moos RH. Ward Atmosphere Scale Manual (A Social Climate Scale). Paolo Alto: Consulting Psychologists Press; 1974.
   Google Scholar
• Moos RH, Shelton R, Petty C. Perceived ward climate and treatment outcome. J Abnorm Psychol. 1973;82(2):291–298. doi:10.1037/h0035184
   PubMed Web of Science ®Google Scholar
• McKellar J, Kelly J, Harris A, Moos R. Pretreatment and during treatment risk factors for dropout among patients with substance use disorders. Addict Behav. 2006;31(3):450–460. doi:10.1016/J.ADDBEH.2005.05.024
   PubMed Web of Science ®Google Scholar
• Marrero CA, Robles RR, Colón HM, et al. Factors associated with drug treatment dropout among injection drug users in Puerto Rico. Addict Behav. 2005;30(2):397–402. doi:10.1016/j.addbeh.2004.05.024
   PubMed Web of Science ®Google Scholar
• Taxman FS, Thanner M, Weisburd D. Risk, Need, and Responsivity (RNR): it all depends. Crime Delinq. 2006;52(1):28–51. doi:10.1177/0011128705281754
   PubMed Web of Science ®Google Scholar
• Stallvik M, Gastfriend DR, Nordahl HM. Matching patients with substance use disorder to optimal level of care with the ASAM criteria software. J Subst Use. 2014;20(6):389–398. doi:10.3109/14659891.2014.934305
   Web of Science ®Google Scholar
• Lappan SN, Brown AW, Hendricks PS. Dropout rates of in-person psychosocial substance use disorder treatments: a systematic review and meta-analysis. Addiction. 2020;115(2):201–217. doi:10.1111/ADD.14793
   PubMed Web of Science ®Google Scholar
• Miller WR. Motivation for treatment. A review with special emphasis on alcoholism. Psychol Bull. 1985;98(1):84–107. doi:10.1037/0033-2909.98.1.84
   PubMed Web of Science ®Google Scholar
• Simpson DD, Joe GW. Motivation as a predictor of early dropout from drug abuse treatment. Psychotherapy. 1993;30(2):357–368. doi:10.1037/0033-3204.30.2.357
   Web of Science ®Google Scholar
• Philips B, Wennberg P. The importance of therapy motivation for patients with substance use disorders. Psychotherapy. 2014;51(4):555–562. doi:10.1037/A0033360
   PubMed Web of Science ®Google Scholar
• Joe GW, Simpson D, Broome KM. Effects of readiness for drug abuse treatment on client retention and assessment of process. Addiction. 1998;93(8):1177–1190. doi:10.1080/09652149835008
   PubMed Web of Science ®Google Scholar
• Sacks S, McKendrick K, Sacks JY, Cleland CM. Modified therapeutic community for co-occurring disorders: single investigator meta-analysis. Subst Abuse. 2010;31(3):146–161. doi:10.1080/08897077.2010.495662
   PubMed Web of Science ®Google Scholar
• Adam EK, Kumari M. Assessing salivary cortisol in large-scale, epidemiological research. Psychoneuroendocrinology. 2009;34(10):1423–1436. doi:10.1016/J.PSYNEUEN.2009.06.011
   PubMed Web of Science ®Google Scholar
• Pruessner JC, Kirschbaum C, Meinlschmid G, Hellhammer DH. Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change. Psychoneuroendocrinology. 2003;28(7):916–931. doi:10.1016/S0306-4530(02)00108-7
   PubMed Web of Science ®Google Scholar
• Stalder T, Kirschbaum C, Kudielka BM, et al. Assessment of the cortisol awakening response: expert consensus guidelines. Psychoneuroendocrinology. 2016;63:414–432. doi:10.1016/j.psyneuen.2015.10.010
   PubMed Web of Science ®Google Scholar
• Nicholson LM, Miller AM, Schwertz D, Sorokin O. Gender differences in acculturation, stress, and salivary cortisol response among former soviet immigrants. J Immigr Minor Health. 2013;15(3):540–552. doi:10.1007/S10903-012-9752-X/TABLES/3
   PubMed Web of Science ®Google Scholar
• Dmitrieva NO, Almeida DM, Dmitrieva J, Loken E, Pieper CF. A day-centered approach to modeling cortisol: diurnal cortisol profiles and their associations among U.S. adults. Psychoneuroendocrinology. 2013;38(10):2354–2365. doi:10.1016/J.PSYNEUEN.2013.05.003
   PubMed Web of Science ®Google Scholar
• de Leon G, Melnick G, Kressel D, Jainchill N. Circumstances, motivation, readiness, and suitability (the CMRS scales): predicting retention in therapeutic community treatment. Am J Drug Alcohol Abuse. 1994;20(4):495–515. doi:10.3109/00952999409109186
   PubMed Web of Science ®Google Scholar
• Derogatis LR, Lipman RS, Rickels K, Uhlenhuth EH, Covi L. The Hopkins Symptom Checklist (HSCL): a self-report symptom inventory. Behav Sci. 1974;19(1):1–15. doi:10.1002/bs.3830190102
   PubMedGoogle Scholar
• Strand BH, Dalgard S, Tambs K, Rognerud M. Measuring the mental health status of the Norwegian population: a comparison of the instruments SCL-25, SCL-10, SCL-5 and MHI-5 (SF-36). Nord J Psychiatry. 2003;57(2):113–118. doi:10.1080/08039480310000932
   PubMed Web of Science ®Google Scholar
• Winhusen T, Kropp F, Babcock D, et al. Motivational enhancement therapy to improve treatment utilization and outcome in pregnant substance users. J Subst Abuse Treat. 2008;35(2):161–173. doi:10.1016/j.jsat.2007.09.006
   PubMed Web of Science ®Google Scholar
• Martino S, Paris MJ, Anez L, et al. The effectiveness and cost of clinical supervision for motivational interviewing: a randomized controlled trial. J Subst Abuse Treat. 2016;68:11–23. doi:10.1016/j.jsat.2016.04.005
   PubMed Web of Science ®Google Scholar
• Santa Ana EJ, LaRowe SD, Armeson K, Lamb KE, Hartwell K. Impact of group motivational interviewing on enhancing treatment engagement for homeless veterans with nicotine dependence and other substance use disorders: a pilot investigation. Am J Addict. 2016;25(7):533–541. doi:10.1111/ajad.12426
   PubMed Web of Science ®Google Scholar
• Smedslund G, Berg RC, Hammerstrom KT, et al. Motivational interviewing for substance abuse. Cochrane Database Syst Rev. 2011;5:CD008063. doi:10.1002/14651858.CD008063.pub2
   PubMed Web of Science ®Google Scholar
• Broome KM, Joe GW, Simpson DD. Engagement models for adolescents in DATOS-A. J Adolesc Res. 2001;16(6):608–623.
   Web of Science ®Google Scholar
• Manetti L, Cavagnini F, Martino E, Ambrogio A. Effects of cocaine on the hypothalamic-pituitary-adrenal axis. J Endocrinol Invest. 2014;37(8):701–708. doi:10.1007/s40618-014-0091-8
   PubMed Web of Science ®Google Scholar
• Haney M, Ward AS, Gerra G, Foltin RW. Neuroendocrine effects of d-fenfluramine and bromocriptine following repeated smoked cocaine in humans. Drug Alcohol Depend. 2001;64(1):63–73. doi:10.1016/S0376-8716(00)00232-5
   PubMed Web of Science ®Google Scholar
• Wemm SE, Sinha R. Drug-induced stress responses and addiction risk and relapse. Neurobiol Stress. 2019;10:100148. doi:10.1016/J.YNSTR.2019.100148
   PubMed Web of Science ®Google Scholar
• Aujla H, Martin-Fardon R, Weiss F. Rats with extended access to cocaine exhibit increased stress reactivity and sensitivity to the anxiolytic-like effects of the mGluR 2/3 agonist LY379268 during abstinence. Neuropsychopharmacology. 2007;33(8):1818–1826. doi:10.1038/sj.npp.1301588
   PubMed Web of Science ®Google Scholar
• Kreek MJ, Koob GF. Drug dependence: stress and dysregulation of brain reward pathways. Drug Alcohol Depend. 1998;51(1–2):23–47. doi:10.1016/S0376-8716(98
   PubMed Web of Science ®Google Scholar
• Koob G, Kreek MJ. Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am J Psychiatry. 2007;164(8):1149–1159. doi:10.1176/APPI.AJP.2007.05030503/ASSET/IMAGES/LARGE/S16F7.JPEG
   PubMed Web of Science ®Google Scholar
• Booth BM, Curran G, Han X, et al. Longitudinal relationship between psychological distress and multiple substance use: results from a three-year multisite natural-history study of rural stimulant users. J Stud Alcohol Drugs. 2015;71(2):258–267. doi:10.15288/JSAD.2010.71.258
   Google Scholar
• Ries R, Wolitzky-Taylor KB, Operskalski JT, Craske MG, Roy-Byrne P. Treatment of comorbid substance use and anxiety disorders: a case study. J Addict Med. 2011;5(4):248–253. doi:10.1097/ADM.0b013e318233d64b
   PubMed Web of Science ®Google Scholar
• Monitoring Centre for Drugs E, Addiction D. Co-morbid substance use and mental disorders in Europe: a review of the data. EMCDDA Papers. Luxembourg: Publications office of the European Union; 2013. doi:10.2810/725386.
   Google Scholar